Johnson & Johnson (JNJ)
Johnson & Johnson Market Cap: 526.07B for Jan. 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 176.33B |
| Gilead Sciences, Inc. | 153.36B |
| Eli Lilly & Co. | 957.06B |
| Regeneron Pharmaceuticals, Inc. | 79.52B |
| Protagonist Therapeutics, Inc. | 5.301B |
Market Cap Related Metrics
| PE Ratio | 21.07 |
| PS Ratio | 5.745 |
| PEG Ratio | 0.2957 |
| Price to Book Value | 6.636 |
| Price to Free Cash Flow | 25.87 |
| Price | 218.35 |
| Earnings Yield | 4.75% |
| PEGY Ratio | 0.2860 |
| Operating PE Ratio | 22.28 |
| Normalized PE Ratio | 25.62 |